Heuron Participates in the Korean Stroke Society's Spring Conference

2024-04-24

Showcases Heuron StroCare Suite™ at Booth

with Positive Feedback on High Sensitivity and Specificity

 


 

At the conference, Heuron showcased its AI solution, Heuron StroCare Suite™, through a booth exhibition and provided demonstration experiences for medical professionals. Heuron StroCare Suite™ is an AI solution that can identify brain hemorrhage or emergency large vessel occlusion andcalculate the ASPECTS score within 3 minutes using only Non-Contrast CT. It has recently been designated as an 'Innovative Medical Technology' by the Ministry of Health and Welfare.

 

Stroke specialists who visited Heuron's booth particularly appreciated that Heuron StroCare Suite™ is capable of analyzing Non-Contrast CT, which is the initial step in stroke patient evaluation, and praised its excellent sensitivity and specificity.

 

Dr. Donghoon Shin, CEO of Heuron, expressed his pleasure in being able to introduce Heuron's solutions directly to a diverse group of stroke specialists and experts at the conference. He stated, "We are delighted to showcase our solution at this academic conference and will continue to strive to make Heuron's solutions widely known not only in Korea but globally, aiding clinicians and contributing to patient care."

 

Meanwhile, Heuron StroCare Suite™, recently designated as an Innovative Medical Technology by the Ministry of Health and Welfare and entering health insurance coverage, will be available for temporary non-insured claims starting from June 1, 2024, for approximately two years.